Hillary Lin, MD
Stanford BS, MD, Internal Medicine Board-Certified Physician Entrepreneur
Co-founder and CEO of Curio - Psychedelic Healthcare Infrastructure Startup
Hillary Lin, MD is a Stanford-trained physician and Co-founder and CEO of Curio, a VC-backed psychedelics healthcare startup. Her research and clinical work has been focused on neuroscience, internal medicine, mental health, and oncology. Dr. Lin additionally advises other practitioners and startups in the health and wellness space. Her mission is to bring transformative, scientific, and accessible change to healthcare.
Dr. Lin writes on a variety of healthcare topics, including psychedelics, mental health, health system reform, and innovation.
Curio is a psychedelics care delivery infrastructure startup focused on remote safety monitoring and clinical outcomes for virtual Psychedelic-Assisted Coaching Treatment (PACT). Its co-founders are Dr. Hillary Lin, CEO and Stanford-trained MD, Felix Li, COO and experienced health/insuretech operator, and Matteo Palvarini, CTO and former LinkedIn engineering manager and Lead Mindfulness Ambassador. Curio's science team is led by CSO Jennifer Huberty, PhD, an NIH-supported researcher who previously led Calm's science division as CSO.Curio's vision is to promote the transformational psychedelic renaissance with its clinical and technology services. Curio is currently serving patients in 4 states.
Keep in Touch